Clinical trial
Exercise Effect on Transthyretin Stability in Master Athletes and Patients With Transthyretin Amyloidosis
NCT04986826 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exercise Effect on Transthyretin Stability in Master Athletes and Patients With Transthyretin Amyloidosis
- Lead sponsor
- Oregon Health and Science University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 15, 2021
- Completion date
- December 30, 2021
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyloidosis transthyretin, athlete heart